Surely part of you wishes we kept the extra $15m from the SPP raise. I guess the extra dilution was not in the best interests of the no.1 shareholder
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-140
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.060(4.00%) |
Mkt cap ! $245.4M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.44 | $57.11K | 38.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2499 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 247 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |